Li Kang Biomedical Dividend
Dividend criteriumcontroles 3/6
Li Kang Biomedical is a dividend paying company with a current yield of 5.64% that is well covered by earnings.
Belangrijke informatie
5.6%
Dividendrendement
-16.0%
Terugkoop Rendement
| Totaal aandeelhoudersrendement | -10.3% |
| Toekomstig dividendrendement | n/a |
| Dividendgroei | 9.9% |
| Volgende betaaldatum dividend | n/a |
| Ex-dividenddatum | n/a |
| Dividend per aandeel | NT$2.500 |
| Uitbetalingsratio | 85% |
Recente dividendupdates
Recent updates
Li Kang Biomedical (GTSM:6242) Has Some Way To Go To Become A Multi-Bagger
Apr 19
Is Li Kang Biomedical Co., Ltd. (GTSM:6242) A Smart Choice For Dividend Investors?
Mar 09Li Kang Biomedical Co., Ltd.'s (GTSM:6242) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Feb 09The Trends At Li Kang Biomedical (GTSM:6242) That You Should Know About
Jan 19We Think Li Kang Biomedical (GTSM:6242) Can Stay On Top Of Its Debt
Dec 29Three Things You Should Check Before Buying Li Kang Biomedical Co., Ltd. (GTSM:6242) For Its Dividend
Dec 08Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: 6242 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Groeiend dividend: 6242's dividend payments have increased, but the company has only paid a dividend for 9 years.
Dividendrendement versus markt
| Li Kang Biomedical Dividendrendement versus markt |
|---|
| Segment | Dividendrendement |
|---|---|
| Bedrijf (6242) | 5.6% |
| Markt onderkant 25% (TW) | 1.7% |
| Markt Top 25% (TW) | 4.4% |
| Gemiddelde industrie (Personal Products) | 4.6% |
| Analist prognose (6242) (tot 3 jaar) | n/a |
Opmerkelijk dividend: 6242's dividend (5.64%) is higher than the bottom 25% of dividend payers in the TW market (1.71%).
Hoog dividend: 6242's dividend (5.64%) is in the top 25% of dividend payers in the TW market (4.42%)
Winstuitkering aan aandeelhouders
Verdiendekking: At its current payout ratio (85%), 6242's payments are covered by earnings.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: With its high cash payout ratio (131.6%), 6242's dividend payments are not well covered by cash flows.